Risk, responsibility, and generic drugs

Ítems similars

• Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
  per: Sarpatwari, Ameet, et al.
  Publicat: (2015)
• Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey
  per: Kesselheim, Aaron S., et al.
  Publicat: (2016)
• Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents
  per: Sacks, Chana A., et al.
  Publicat: (2018)
• Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans
  per: Fischer, Michael A, et al.
  Publicat: (2003)
• Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval
  per: Kesselheim, Aaron S., et al.
  Publicat: (2016)